ARCHIVES

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Ultmann New AACI President, Robert Day Named President Elect; Hulka New DCPC Board Chairman

July 20, 1984

NCI RFP Available.

February 11, 2000

Gleevec Approved For Pediatric CML

May 23, 2003

Karlan To Succeed Hoskins As Chairman, DOD Ovarian Cancer Program Advisory Panel.

July 27, 2001

More Bad News for AVEO As Tivozanib Partner Bids Adieu

May 31, 2013

Gonzalez-Angulo To Serve 10 Years In Poisoning Case

October 3, 2014